Qsemble Capital Management, LP
Position in IONS — Ionis Pharmaceuticals Inc
CIK 1766159
New York, NY
Position in IONS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$308,200
-$1,625,968 QoQ
Shares Held
3,887
-84.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#339
of 510 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $7,848,553 across 6 Biotechnology names. IONS ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
31,633 | $2,356,025 | |
| 2 | INSM |
INSMED Inc
|
21,148 | $2,254,799 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
47,971 | $1,871,348 | |
| 4 | RPRX |
Royalty Pharma plc
|
10,675 | $598,547 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,639 | $459,634 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
This page
|
3,887 | $308,200 |
All Filings in IONS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $308,200 | 3,887 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,934,168 | 25,758 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,181,774 | 27,579 | Shares | Sole | 2026-02-05 | |
| 2024-12-31 | $1,628,192 | 46,573 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||